<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
    <channel>
        <title><![CDATA[AZD7442 Feed]]></title>
        <description><![CDATA[AZD7442 articles]]></description>
        <link>https://sps.devopsroom.com</link>
        <generator>stiripesurse.ro</generator>
        <lastBuildDate>Wed, 17 Jun 2026 18:15:24 GMT</lastBuildDate>
        <atom:link href="https://sps.devopsroom.com/tag/azd7442/feed" rel="self" type="application/xml"/>
        <pubDate>Wed, 17 Jun 2026 18:15:24 GMT</pubDate>
        <language><![CDATA[ro-RO]]></language>
                <item>
            <title><![CDATA[Evusheld de la AstraZeneca își păstrează acțiunea neutralizantă împotriva variantelor Omicron BA.4 și BA.5, conform unui nou studiu al Universității Oxford]]></title>
            <description><![CDATA[Evusheld de la AstraZeneca își păstrează acțiunea neutralizantă împotriva variantelor Omicron BA.4 și BA.5, conform unui nou studiu al Universității Oxford]]></description>
            <link>https://sps.devopsroom.com/evusheld-de-la-astrazeneca-isi-pastreaza-actiunea-neutralizanta-impotriva-variantelor-omicron-ba4-si-ba5-conform-unui-nou-studiu-al-universitatii-oxford_2403480.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/evusheld-de-la-astrazeneca-isi-pastreaza-actiunea-neutralizanta-impotriva-variantelor-omicron-ba4-si-ba5-conform-unui-nou-studiu-al-universitatii-oxford_2403480.html</guid>
                        <category><![CDATA[studiu]]></category>
                        <category><![CDATA[Universitatea din Oxford]]></category>
                        <category><![CDATA[astrazeneca]]></category>
                        <category><![CDATA[COVID-19]]></category>
                        <category><![CDATA[AZD7442]]></category>
                        <category><![CDATA[Evusheld]]></category>
                        <category><![CDATA[Omicron]]></category>
                        <category><![CDATA[tixagevimab]]></category>
                        <category><![CDATA[cilgavimab]]></category>
                        <category><![CDATA[John L. Perez]]></category>
                        <category><![CDATA[Sănătate]]></category>
                        <dc:creator><![CDATA[Denisa Miron, Colaborator]]></dc:creator>
            <pubDate>Fri, 27 May 2022 14:41:54 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202204/1600x900/media-165055709777608300.webp" length="0" type="image/webp"/>
        </item>
                <item>
            <title><![CDATA[Evusheld demonstrează protecție semnificativă împotriva formelor simptomatice de COVID-19 pentru o perioadă de minim 6 luni în cadrul studiului clinic de fază I]]></title>
            <description><![CDATA[Evusheld demonstrează protecție semnificativă împotriva formelor simptomatice de COVID-19 pentru o perioadă de minim 6 luni în cadrul studiului clinic de fază I]]></description>
            <link>https://sps.devopsroom.com/evusheld-demonstreaza-protectie-semnificativa-impotriva-formelor-simptomatice-de-covid-19-pentru-o-perioada-de-minim-6-luni-in-cadrul-studiului-clinic-de-faza-i_2384945.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/evusheld-demonstreaza-protectie-semnificativa-impotriva-formelor-simptomatice-de-covid-19-pentru-o-perioada-de-minim-6-luni-in-cadrul-studiului-clinic-de-faza-i_2384945.html</guid>
                        <category><![CDATA[New England Journal of Medicine]]></category>
                        <category><![CDATA[astrazeneca]]></category>
                        <category><![CDATA[COVID-19]]></category>
                        <category><![CDATA[AZD7442]]></category>
                        <category><![CDATA[Evusheld]]></category>
                        <category><![CDATA[tixagevimab]]></category>
                        <category><![CDATA[cilgavimab]]></category>
                        <category><![CDATA[omicron BA.2]]></category>
                        <category><![CDATA[AstraZeneca Evusheld]]></category>
                        <category><![CDATA[Myron J. Levin]]></category>
                        <category><![CDATA[Sănătate]]></category>
                        <dc:creator><![CDATA[Denisa Miron, Colaborator]]></dc:creator>
            <pubDate>Mon, 16 May 2022 08:41:28 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202204/1600x900/media-165055709777608300.webp" length="0" type="image/webp"/>
        </item>
                <item>
            <title><![CDATA[Cum pot fi evitate formele grave de COVID-19 la pacienții vulnerabili]]></title>
            <description><![CDATA[Cum pot fi evitate formele grave de COVID-19 la pacienții vulnerabili]]></description>
            <link>https://sps.devopsroom.com/cum-pot-fi-evitate-formele-grave-de-covid-19-la-pacientii-vulnerabili_2131745.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/cum-pot-fi-evitate-formele-grave-de-covid-19-la-pacientii-vulnerabili_2131745.html</guid>
                        <category><![CDATA[virus]]></category>
                        <category><![CDATA[studiu]]></category>
                        <category><![CDATA[University College]]></category>
                        <category><![CDATA[Agenția Europeană a Medicamentului]]></category>
                        <category><![CDATA[EMA]]></category>
                        <category><![CDATA[astrazeneca]]></category>
                        <category><![CDATA[COVID-19]]></category>
                        <category><![CDATA[SARS-CoV-2]]></category>
                        <category><![CDATA[Virgil Musta]]></category>
                        <category><![CDATA[pacienti vulnerabili]]></category>
                        <category><![CDATA[anticorpii monoclonali]]></category>
                        <category><![CDATA[AZD7442]]></category>
                        <category><![CDATA[Hugh Montgomery]]></category>
                        <category><![CDATA[TACKLE]]></category>
                        <category><![CDATA[Frontiers in Medicine]]></category>
                        <category><![CDATA[Știrile Zilei]]></category>
                        <category><![CDATA[Sănătate]]></category>
                        <category><![CDATA[Instant Articles]]></category>
                        <dc:creator><![CDATA[Alexandra Cruceru, Redactor]]></dc:creator>
            <pubDate>Tue, 07 Dec 2021 07:44:20 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202110/1600x900/media-163552916438950500.webp" length="0" type="image/webp"/>
        </item>
                <item>
            <title><![CDATA[Cine poate beneficia de noul tratament cu anticorpi monoclonali, eficient împotriva infectării cu SARS-CoV-2]]></title>
            <description><![CDATA[Cine poate beneficia de noul tratament cu anticorpi monoclonali, eficient împotriva infectării cu SARS-CoV-2]]></description>
            <link>https://sps.devopsroom.com/cine-poate-beneficia-de-noul-tratament-cu-anticorpi-monoclonali-eficient-impotriva-infectarii-cu-sars-cov-2_2096875.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/cine-poate-beneficia-de-noul-tratament-cu-anticorpi-monoclonali-eficient-impotriva-infectarii-cu-sars-cov-2_2096875.html</guid>
                        <category><![CDATA[Agenția Europeană a Medicamentului]]></category>
                        <category><![CDATA[EMA]]></category>
                        <category><![CDATA[astrazeneca]]></category>
                        <category><![CDATA[Spitalul de Boli Infecţioase ”Victor Babeş” din Timisoara]]></category>
                        <category><![CDATA[SARS-CoV-2]]></category>
                        <category><![CDATA[Virgil Musta]]></category>
                        <category><![CDATA[pacienti vulnerabili]]></category>
                        <category><![CDATA[anticorpi monoclonali]]></category>
                        <category><![CDATA[AZD7442]]></category>
                        <category><![CDATA[Covid-19 EMA Pandemic Task Force]]></category>
                        <category><![CDATA[Mene Pangalos]]></category>
                        <category><![CDATA[BioPharmaceuticals]]></category>
                        <category><![CDATA[Știrile Zilei]]></category>
                        <category><![CDATA[Sănătate]]></category>
                        <dc:creator><![CDATA[Alexandra Cruceru, Redactor]]></dc:creator>
            <pubDate>Mon, 15 Nov 2021 12:11:20 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202111/1600x900/media-163697743765554200.webp" length="0" type="image/webp"/>
        </item>
                <item>
            <title><![CDATA[Noul tratament cu anticorpi AstraZeneca poate elimina decesul și orice evoluție severă a infectării cu Covid-19]]></title>
            <description><![CDATA[Noul tratament cu anticorpi AstraZeneca poate elimina decesul și orice evoluție severă a infectării cu Covid-19]]></description>
            <link>https://sps.devopsroom.com/noul-tratament-cu-anticorpi-astrazeneca-poate-elimina-decesul-si-orice-evolutie-severa-a-infectarii-cu-covid-19_2071039.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/noul-tratament-cu-anticorpi-astrazeneca-poate-elimina-decesul-si-orice-evolutie-severa-a-infectarii-cu-covid-19_2071039.html</guid>
                        <category><![CDATA[vaccin]]></category>
                        <category><![CDATA[interventie]]></category>
                        <category><![CDATA[tratament]]></category>
                        <category><![CDATA[deces]]></category>
                        <category><![CDATA[teste]]></category>
                        <category><![CDATA[terapii]]></category>
                        <category><![CDATA[astrazeneca]]></category>
                        <category><![CDATA[anticorpi]]></category>
                        <category><![CDATA[COVID-19]]></category>
                        <category><![CDATA[AZD7442]]></category>
                        <category><![CDATA[Mene Pangalos]]></category>
                        <category><![CDATA[Evusheld]]></category>
                        <category><![CDATA[PROVENT]]></category>
                        <category><![CDATA[Noul tratament cu anticorpi Astrazeneca]]></category>
                        <category><![CDATA[evolutia severa]]></category>
                        <category><![CDATA[Știrile Zilei]]></category>
                        <category><![CDATA[Externe]]></category>
                        <category><![CDATA[Sănătate]]></category>
                        <category><![CDATA[Sinteze]]></category>
                        <category><![CDATA[Instant Articles]]></category>
                        <category><![CDATA[Parteneri Articole]]></category>
                        <category><![CDATA[Tarom AirFi]]></category>
                        <dc:creator><![CDATA[Cristi Șelaru, Redactor]]></dc:creator>
            <pubDate>Fri, 29 Oct 2021 18:33:51 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202110/1600x900/media-163552916438950500.webp" length="0" type="image/webp"/>
        </item>
                <item>
            <title><![CDATA[Premieră: AstraZeneca oferă primul tratament cu anticorpi care poate proteja pacienții vulnerabili în fața Covid-19]]></title>
            <description><![CDATA[Premieră: AstraZeneca oferă primul tratament cu anticorpi care poate proteja pacienții vulnerabili în fața Covid-19]]></description>
            <link>https://sps.devopsroom.com/premiera-astrazeneca-ofera-primul-tratament-cu-anticorpi-care-poate-proteja-pacientii-vulnerabili-in-fata-covid-19_2052588.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/premiera-astrazeneca-ofera-primul-tratament-cu-anticorpi-care-poate-proteja-pacientii-vulnerabili-in-fata-covid-19_2052588.html</guid>
                        <category><![CDATA[teste]]></category>
                        <category><![CDATA[astrazeneca]]></category>
                        <category><![CDATA[comorbiditati]]></category>
                        <category><![CDATA[pacienti vulnerabili]]></category>
                        <category><![CDATA[tratament cu anticorpi]]></category>
                        <category><![CDATA[AZD7442]]></category>
                        <category><![CDATA[Hugh Montgomery]]></category>
                        <category><![CDATA[Covid-19 EMA Pandemic Task Force]]></category>
                        <category><![CDATA[Mene Pangalos]]></category>
                        <category><![CDATA[efect profilactic]]></category>
                        <category><![CDATA[combinatie de anticorpi monoclonali]]></category>
                        <category><![CDATA[COVID-ETF]]></category>
                        <category><![CDATA[TACKLE]]></category>
                        <category><![CDATA[Știrile Zilei]]></category>
                        <category><![CDATA[Sănătate]]></category>
                        <category><![CDATA[Sinteze]]></category>
                        <category><![CDATA[Instant Articles]]></category>
                        <dc:creator><![CDATA[Lucian Negrea, Reporter]]></dc:creator>
            <pubDate>Tue, 19 Oct 2021 05:01:00 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202110/1600x900/media-163459391169255300.webp" length="0" type="image/webp"/>
        </item>
            </channel>
</rss>
